HomeCompareELXMF vs NOBL

ELXMF vs NOBL: Dividend Comparison 2026

ELXMF yields 105263.16% · NOBL yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ELXMF wins by $8.064713171987811e+26M in total portfolio value
10 years
ELXMF
ELXMF
● Live price
105263.16%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8.064713171987811e+26M
Annual income
$804,966,999,868,734,400,000,000,000,000,000.00
Full ELXMF calculator →
NOBL
NOBL
● Live price
2.14%
Share price
$106.01
Annual div
$2.27
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.8K
Annual income
$246.19
Full NOBL calculator →

Portfolio growth — ELXMF vs NOBL

📍 ELXMF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodELXMFNOBL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ELXMF + NOBL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ELXMF pays
NOBL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ELXMF
Annual income on $10K today (after 15% tax)
$8,947,368.42/yr
After 10yr DRIP, annual income (after tax)
$684,221,949,888,424,200,000,000,000,000,000.00/yr
NOBL
Annual income on $10K today (after 15% tax)
$182.19/yr
After 10yr DRIP, annual income (after tax)
$209.26/yr
At 15% tax rate, ELXMF beats the other by $684,221,949,888,424,200,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ELXMF + NOBL for your $10,000?

ELXMF: 50%NOBL: 50%
100% NOBL50/50100% ELXMF
Portfolio after 10yr
$4.0323565859939053e+26M
Annual income
$402,483,499,934,367,200,000,000,000,000,000.00/yr
Blended yield
99.81%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ELXMF buys
0
NOBL buys
0
No recent congressional trades found for ELXMF or NOBL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricELXMFNOBL
Forward yield105263.16%2.14%
Annual dividend / share$2.00$2.27
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$8.064713171987811e+26M$22.8K
Annual income after 10y$804,966,999,868,734,400,000,000,000,000,000.00$246.19
Total dividends collected$8.063727433132777e+26M$2.3K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: ELXMF vs NOBL ($10,000, DRIP)

YearELXMF PortfolioELXMF Income/yrNOBL PortfolioNOBL Income/yrGap
1← crossover$10,537,016$10,526,315.79$10,914$214.34+$10.53MELXMF
2$10,377,251,773$10,365,977,166.23$11,897$218.63+$10377.24MELXMF
3$9,552,044,282,229$9,540,940,622,831.33$12,952$222.72+$9552044.27MELXMF
4$8,217,919,074,277,338$8,207,698,386,895,354.00$14,086$226.62+$8217919074.26MELXMF
5$6,608,173,294,209,699,000$6,599,380,120,800,222,000.00$15,302$230.33+$6608173294209.68MELXMF
6$4,966,582,566,903,309,000,000$4,959,511,821,478,505,000,000.00$16,607$233.85+$4966582566903309.00MELXMF
7$3,488,939,161,660,980,000,000,000$3,483,624,918,314,393,500,000,000.00$18,007$237.18+$3488939161660979712.00MELXMF
8$2,290,823,651,613,942,000,000,000,000$2,287,090,486,710,964,800,000,000,000.00$19,508$240.35+$2.2908236516139422e+21MELXMF
9$1,405,904,046,772,744,300,000,000,000,000$1,403,452,865,465,517,400,000,000,000,000.00$21,116$243.35+$1.4059040467727442e+24MELXMF
10$806,471,317,198,781,100,000,000,000,000,000$804,966,999,868,734,400,000,000,000,000,000.00$22,841$246.19+$8.064713171987811e+26MELXMF

ELXMF vs NOBL: Complete Analysis 2026

ELXMFStock

Nova Eye Medical Limited designs, develops, distributes, markets, sells, and services surgical devices for the treatment of glaucoma. The company offers iTrack, a surgical system for the reduction in intraocular pressure (IOP) in adult patients with open-angle glaucoma; iTrack Advance, a natural ocular drainage system; Molteno3, a glaucoma drainage device to treat patients with severe or complex glaucoma; and 2RT, a proprietary laser technology to treat patients in early/intermediate age-related macular degeneration. It operates in Australia, the United States, Europe, the Asia Pacific, and internationally. The company was formerly known as Ellex Medical Lasers Limited and changed its name to Nova Eye Medical Limited in July 2020. Nova Eye Medical Limited was founded in 1985 and is headquartered in Kent Town, Australia.

Full ELXMF Calculator →

NOBLETF

The fund will invest at least 80% of its total assets in component securities of the index. The index contains a minimum of 40 stocks, which are equally weighted, and no single sector is allowed to comprise more than 30% of the index weight. It seeks to remain fully invested at all times in securities and/or financial instruments that, in combination, provide exposure to the returns of the index without regard to market conditions, trends or direction.

Full NOBL Calculator →
📬

Get this ELXMF vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ELXMF vs SCHDELXMF vs JEPIELXMF vs OELXMF vs KOELXMF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.